Metabolic abnormalities characteristic of syndrome predict the development of transplant coronary artery disease: A prospective study

Circulation

Volumn 103, Issue 17, 2001, Pages 2144-2152

  Valantine, Hannah ^a,b   Rickenbacker, Peter ^a   Kemna, Mariska ^a   Hunt, Sharon ^a   Chen, Y D Ida ^a   Reaven, Gerald ^a   Stinson, Edward B ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Hyperinsulinemia; Hypertriglyceridemia; Insulin; Transplantation

Indexed keywords

GLUCOSE; INSULIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; AUTOPSY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; HEART TRANSPLANTATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035337156     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.17.2144     Document Type: Article

References (12)

1. Rickenbacher PR, Kemna MS, Pinto FJ, et al. Coronary artery intimai thickening in the transplanted heart: an in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. Transplantation. 1996; 61:46-53.
2. Reaven GM, Chen YDI. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev. 1988;4:639-652.
3. St Goar FG, Pinto FJ, Alderman EL, et al. Intravascular ultrasound imaging of angiographically normal coronary arteries: an in vivo comparison with quantitative angiography. J Am Coll Cardiol. 1991; 18: 952-958.
4. Rickenbacher PR, Pinto FJ, Lewis NP, et al. Prognostic importance of intimai thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation. 1995;92:3445-3452.
5. Velican D, Velican C. Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis. 1981;38:39-50.
6. Mehra M, Ventura HO, Chambers R, et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol. 1995;26:1537-1544.
7. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996; 334:952-957.
8. Wincour PH, Durrington PN, Ishola M, et al. Abnormalities of VLDL, IDL and LDL characterize insulin-dependent diabetes mellitus. Atherosclerosis. 1992;12:920-928.
9. Ballantyne C, Podet FJ, Patsch WP, et al. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 1989;262:53-56.
10. Renlund DG, Bristow MR, Crandall BG, et al. Hyperlipidemia after transplantation: amelioration with corticosteroid-free maintenance immunosuppression. J Heart Transplant. 1998;8:214-220.
11. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333: 621-627.
12. Wenke K, Meiser B, Thiery J, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation. 1997;96:1398-1402.